Rationale It is becoming increasingly clear that the development of treatments for cognitive symptoms of schizophrenia requires urgent attention, and that valid animal models of relevant impairments are required. With subchronic psychotomimetic agent phencyclidine (scPCP), a putative model of such impairment, the extent to which changes following scPCP do or do not resemble those following dysfunction of the prefrontal cortex is of importance. Objectives The present study carried out a comparison of the most common scPCP dosing regimen with excitotoxininduced medial prefrontal cortex (mPFC) dysfunction in rats, across several cognitive tests relevant to schizophrenia. Methods ScPCP subjects were dosed intraperitoneal with 5 mg/kg PCP or vehicle twice daily for 1 week followed by 1 week washout prior to behavioural testing. mPFC dysfunction was induced via fibre-sparing excitotoxin infused into the pre-limbic and infralimbic cortex. Subjects were tested on spontaneous novel object recognition, touchscreen objectlocation paired-associates learning and touchscreen reversal learning. Results A double-dissociation was observed between objectlocation paired-associates learning and object recognition: mPFC dysfunction impaired acquisition of the objectlocation task but not spontaneous novel object recognition, while scPCP impaired spontaneous novel object recognition but not object-location associative learning. Both scPCP and mPFC dysfunction resulted in a similar facilitation of reversal learning. Conclusions The pattern of impairment following scPCP raises questions around its efficacy as a model of cognitive impairment in schizophrenia, particularly if importance is placed on faithfully replicating the effects of mPFC dysfunction.
Introduction
It is becoming increasingly clear that the development of treatments for the cognitive symptoms of schizophrenia requires urgent attention (Minzenberg and Carter 2012; Schaefer et al. 2013; Vingerhoets et al. 2013) . To achieve this aim, we need valid animal models of the cognitive impairments in schizophrenia (Nestler and Hyman 2010) . The psychotomimetic agent phencyclidine (PCP) has been widely used to model schizophrenia in rodents (Castner et al. 2004; Neill et al. 2010) . In humans, PCP and other N-methyl-D-aspartate receptor (NMDAR) antagonists can induce the symptoms of schizophrenia and cause relapse for schizophrenics stabilized on anti-psychotic medication (Itil et al. 1967; Javitt and Zukin 1991; Krystal et al. 1994; Lahti et al. 1995 Lahti et al. , 2001 Malhotra et al. 1996 Malhotra et al. , 1997 Snyder 1980; Tamminga 1998) . These observations are consistent with the 'glutamate hypothesis of schizophrenia', which posits that NMDAR function is disrupted in schizophrenia (Javitt et al. 2012; Poels et al. 2014; Singh and Singh 2011) .
Subchronic PCP (scPCP) in particular has many prima facie advantages (Table 1) . For example, cognitive impairments relevant to schizophrenia have been observed following scPCP (Arnt et al. 2010; Barnes et al. 2012; Beninger et al. 2010; Howes et al. 2015; Laurent and Podhorna 2004; McKibben et al. 2010; Meltzer et al. 2013) and the model, like other subchronic treatments, allows assessment of the effects of the treatment when the drug is no longer 'on board', thus minimizing motoric and/or motivational changes which can seriously confound cognitive testing and subsequent interpretation of the results.
Another attraction of the scPCP model is the assumption that it induces dysfunction of the prefrontal cortex (Amitai et al. 2012; Young et al. 2015) , a major feature of the schizophrenic brain often cited as a major contributor to cognitive deficits (Glahn et al. 2005; Hill et al. 2004; Ingvar and Franzen 1974) . Therefore, the extent to which changes following scPCP do or do not resemble those found following dysfunction of the prefrontal cortex is of some importance to researchers in this area. Therefore, in the present study, we carried out a head-to-head comparison of the effects of the most common scPCP dosing regimen (5 mg/kg twice daily for 7 days followed by 7 days washout), with the effects of fibre-sparing excitotoxin-induced medial prefrontal cortex (mPFC) dysfunction in rats, across several cognitive tests relevant to schizophrenia: object-location paired-associates learning, spontaneous novel object recognition and reversal learning.
Object-location learning (experiment 1) Object-location learning, for example, as studied using the CANTAB pairedassociates learning (PAL) test (Sahakian et al. 1988) , can be used to investigate the MATRICS domain of visual learning and memory and the CNTRICS domain of long term memory. Impairments in object-location PAL have been found in chronic schizophrenia (Aubin et al. 2009; Donohoe et al. 2008; Haring et al. 2014; Wood et al. 2002) and can also be present at first onset of the disorder and may predict following clinical severity (Barnett et al. 2005) . Additionally, impairments on CANTAB PAL have been observed during the prodromal phase and may be present in relatives at risk of developing schizophrenia (Bartok et al. 2005) . Normal performance of CANTAB PAL depends on the medial temporal lobe (Wood et al. 2002) and prefrontal cortex (Owen et al. 1995) .
The rodent object-location PAL was inspired by the CAN-TAB PAL task (Talpos et al. 2009 ) and has been recommended by CNTRICS for studying long-term memory in animal models of schizophrenia (Bussey et al. 2013 ).
Object recognition (experiment 2) Spontaneous object recognition (SOR) has been used to examine non-spatial memory impairments linked to schizophrenia (Dere et al. 2007; Lyon et al. 2012) . In studies of SOR and scPCP immediately postwashout, significant impairments were observed following various retention periods (Arnt et al. 2010; Horiguchi et al. 2011; McKibben et al. 2010; Snigdha et al. 2010) . Additionally, object recognition impairments following scPCP are attenuated by clozapine and risperidone but not haloperidol (Grayson et al. 2007 ).
Reversal learning (experiment 3) Reversal learning assesses the subject's ability to acquire a simple 'rule' and then adopt a new strategy when the rule no longer holds. Reversal learning is impaired in schizophrenia (Leeson et al. 2009; McKirdy et al. 2009; Murray et al. 2008; Waltz and Gold 2007) and has been recommended by CNTRICS for studying executive function in animal models of schizophrenia (Gilmour et al. 2013) . First, rats learn to discriminate between an S+ and S− by perceptually discriminating between S+ and S− and learning the reward contingency. Once the subject has acquired the discrimination, the reward contingency is reversed (S+ becomes the S−). The reversal stage requires the subject to inhibit responding to the previously rewarded stimulus and switch to the new reward contingencies.
Reversal learning ability is dependent on the orbitofronal cortex (Bissonette et al. 2008; Burke et al. 2009; Chudasama and Robbins 2003) and striatum (Ragozzino 2007; Ragozzino et al. 2002) . Previous studies have found impairments in reversal learning in schizophrenia (McKirdy et al. 2009; Murray et al. 2008; Schlagenhauf et al. 2014; Waltz and Gold 2007) , which are present following correction for IQ (Leeson et al. 2009 ), consistent with hypofrontality in schizophrenia.
Methods
Apparatus Rat touchscreen chambers were the same as those used in previous touchscreen studies (McAllister et al. 2013; Bussey et al. 2008; Talpos et al. 2009 ). The object recognition Y-maze apparatus was the same as used by Forwood et al. (2005) and Winters et al. (2004) . Three identical copies were used of each object with no natural significance or previous presentation.
Surgery mPFC lesions generally followed the adaptation of Birrell and Brown's (2000) protocol, used in previous touchscreen studies centred on prelimbic and infralimbic cortices (McAllister et al. 2013) . Bilateral injections of 0.2 μL of 0.06 M ibotenic acid (Sigma, UK) or vehicle were made at AP +3.5, L ±0.6, V −5.2; AP+ 2.5, L ±0.6, V −5.0 mm, relative to skull surface Bregma via custom infusing line and 10 μL Hamilton syringe and Harvard Instruments Pump 11 (Holliston, Massachusetts) pump. Subjects recovered for at least 1 week with ad libitum food and water prior to behavioural testing.
Histology Protocol followed previous touchscreen studies of lesions centred on mPFC (McAllister et al. 2013) . Coronal sections (60 μm) were stained with NeuN, and lesion locations were mapped onto standardized sections of the (Paxinos and Watson 2007) atlas of the rat brain.
Subchronic phencyclidine protocol Rats were dosed with 5 mg/kg PCP (Sigma, UK) via intraperitoneal injection (5 mg/mL) or 1 mL/kg vehicle twice daily (7:30 a.m./p.m.) for 7 days, followed by a 7-day washout period prior to behavioural testing.
Touchscreen testing protocol Rats were group-housed on a reverse light-dark schedule (light 7 p.m.-7 a.m.) and tested during dark phase. A restricted diet maintained rats at no less than 85 % of free-feeding weight, with water available ad libitum. Pre-training touchscreen use prior to object-location or reversal learning tasks followed established protocols Horner et al. 2013; McAllister et al. 2013) . This experiment was conducted in accordance with the UK Animals (Scientific Procedures) Act, 1986.
Object-location learning (experiment 1) scPCP treatment Sixteen male 250-275 g Lister Hooded rats were obtained from Harlan, UK. After completion of pretraining, rats were pseudorandomly allocated to PCP or vehicle treatment groups. Following scPCP protocol, rats completed 2 days of 'punish for incorrect' pre-training at criterion levels before PAL acquisition. PAL acquisition generally followed protocols established by Talpos et al. (2009) with the exception that rats were tested twice daily over 11 blocks of 5 sessions each. mPFC lesions Sixteen male 250-275 g Lister Hooded rats were obtained from Harlan, UK. Behavioural methods were initially identical to those in experiment 1 scPCP, but as a difference between groups was observed, testing was extended to 17 blocks to explore the persistence of the deficit. Following acquisition of dPAL, an object-location challenge took place: the foil stimulus was replaced with the correct stimulus for all trials (sPAL protocol; Talpos et al. 2009 ; Fig. 1 ).
Behavioural testing
In this task, three images are used as objects, each correct when presented in one of three response locations, and incorrect when presented in either of the other two. There are six unique trial types of one object in its correct location and a different foil object in an incorrect location (the 'dPAL' version of the task; Talpos et al. 2009 ; Fig. 1 ). Talpos et al. (2009) demonstrated that pharmacological manipulations of the hippocampus could impair performance of PAL, consistent with human imaging studies showing the hippocampus activated during encoding and parahippocampal gyrus during retrieval of the CANTAB PAL task (de Rover et al. 2011) . Dependency on mPFC has not previously been investigated. In this first experiment, we tested the effects of scPCP on the touchscreen PAL test (Figs. 2 and 3 ).
Object recognition (experiment 2)
The same scPCP and mPFC rats were used as in experiment 1 and maintained under the same housing conditions. Experiment 2 took place immediately following PAL acquisition, with initial habituation beginning the day following the last session of PAL.
Three daily 5-min habituation sessions followed by two sets of discriminations with novel object, order and novel side counterbalanced. Discrimination trials consisted of 3-min exposure to two copies of the same object (sample phase), delay, then 3-min choice phase with a third copy of the pre-exposed object and a novel object. The apparatus and objects were wiped down with a dilute ethanol solution between trials to prevent olfactory trails. A minimum of 20 s exploration during sample phase was required for analysis, defined as nose oriented towards the object within 2 cm. Discrimination scores tNovel−tSample tNovelþtSample were calculated for the total time as well as the first minute.
In addition, this experiment allowed testing of the persistence of the functional effects of scPCP, as it is conceivable that the lack of effect of scPCP on PAL in experiment 1 was due to the effects of scPCP decreasing over time. Indeed, longitudinal testing of the effects of scPCP post-washout is not common, with most testing taking place fewer than 7 days post-washout. Thus, we tested the same rats used in experiment 1 on spontaneous object recognition at two time-points: 40 and 105 days post-washout. Reversal learning (experiment 3)
Thirty-two male 250-275 g Lister Hooded rats were obtained from Harlan, UK and housed as in PAL protocol, above. Behavioural testing took place in the touchscreen chambers used in experiment 1, with screen masking adapted for two choices. Acquisition consisted of daily 1-h sessions of up to 100 trials until all subjects reached stable criterion of greater than 80 % across three consecutive days. Subjects were p s eu d o r a n do m l y a s s i g ne d t o t r e a t m e n t g r o u p s , counterbalancing for performance. All rats immediately rebaselined at criterion and reversal began on day 4 post-washout/11 post-lesion. Maximum session length was 100 trials or 1 h, with the first session split into shorter sessions of 25, 25 and 50 trials (one session/day) to ensure completion of trials (summed to session 1). Rats were tested for 18 sessions.
Results

Experiment 1: effects of scPCP on acquisition of the PAL task
Repeated-measures analysis of variance (ANOVA) did not demonstrate a significant effect of scPCP in acquisition of object-location paired-associates learning (F (1-14) =0.675, p= 0.43), and both groups reached 80 % correct by block 11. At this point, rats moved on to experiment 2. Log transformed reaction times significantly decreased across acquisition (F( 2.37, 33.12) =16.31, p<0.001) with no significant effect of scPCP (F( 1, 14) =0.89, p = 0.361). Magazine latency also decreased across acquisition (F (10, 14) =2.67, p=0.005), with no significant effect of scPCP (F( 1, 14) =0.11, p=0.92).
Experiment 1: mPFC dysfunction and PAL acquisition
Histological results Histology confirmed lesions of the medial prefrontal cortex in all rats, centred on the pre-limbic and infralimbic cortices with damage to overlying anterior cingulate cortex. Shams did not show significant damage to any of those regions. One lesion was excluded from data analysis as largely unilateral, resulting in eight sham and seven lesions.
Behavioural results Repeated measures ANOVA demonstrated significant main effect of lesion (F (1, 12) =5.01, p= 0.045) and session block (F (7.87, 54) =63.8, p<0.001), with no interaction (F (7.87, 54) =1.74, p=0.099). Performance appeared to asymptote slightly below 90 % correct for shams and 80 % correct for lesions (no significant learning over blocks 17-19: shams (F (2, 12) =0.25, p=0.78; lesion F (2, 12) = 0.23, p=0.80). Response latencies reduced over the course of acquisition (F (7.42, 81.6) =1.94, <0.001), with no significant difference between sham and lesion (F (1, 11) =1.46, p=0.25 or latency to magazine (F (1, 11) =0.32, p=0.86).
During the mPFC object-location challenge, there was no significant difference in performance between dPAL and sPAL for sham (t (12) =0.46, p=0.65) or lesion (t (12) =0.59, p=0.56), suggesting both groups used an object-location strategy (rather than, e.g. a conditional strategy). The lesion group was impaired on both sPAL and dPAL (dPAL t (12) =3.05, p= 0.01; sPAL t (12) =2.14, p=0.044). To further probe the nature of task acquisition, analysis of individual trial types was then undertaken.
Analysis showed different rates of learning of each trial type-not unexpected, as it is likely an animal would, for various reasons, work out some of the object-location bindings before others. Interestingly, however, initial examination by trial type across acquisition found greater variance in the lesion group versus shams, suggesting that the lesion group had not fully solved all of the object-location paired-associates.
To quantify this variability, we calculated, for each rat, mean standard deviation on each of the six trial types throughout acquisition (Fig. 4 ). There was a significant effect of block (ANOVA F (8.4, 108) =2.94, p<0.01) and a significant lesion× block interaction (F (8.4, 108) =2.53, p=0.01) as the sham group learned to perform all trial types with greater proficiency, whereas the rats in the lesion group learned some trial types but not others.
Experiment 2: scPCP and object recognition
Both 1-and 3-min discrimination scores showed significant decrease in preference for the novel object in the scPCP group at 6 but not 15 weeks post-washout (Fig. 5) . There was no significant difference between sham and lesion in overall exploration time during sample or choice at 6 weeks (sample t (12) =0.086, p=0.51; choice t (12) =0.82, p=0.43). scPCP significantly impaired novel object recognition at a 1-h delay compared with vehicle t (12) =2.55, p<0.01, with the scPCP discrimination score not significantly greater than chance (t (6) =1.69, p=0.14).
Re-testing 3 months (105 days) post-washout found no impairment in scPCP at a 1-or 24-h delay ( Fig. 5; 1 
Experiment 2: mPFC dysfunction and object recognition
One-and three-minute discrimination scores showed no significant difference between lesion and sham rats at 1-or 24-h delays ( Fig. 6; 1 =0.93, p=0.37, t (12) =0.55, p=0.60).
There were no significant differences in exploration time in sample or choice phase at a 1-h (sample: t (12) =1.53, p=0.15; choice: t (12) =0.78, p=0.45) or 24-h delay (sample: t (12) =0.52, p=0.61; choice: t (12) =1.03, p=0.32). Discrimination scores at the 24-h delay were significantly greater than chance for both sham and lesion (sham: t (6) =4.51, p=0.004; lesion: t (6) =3.14, p=0.016). Experiment 3: scPCP and reversal learning scPCP rats were significantly faster to reach the reversal learning criterion (80 % accuracy over two consecutive sessions) than control rats both in errors to criterion (t (14) =1.78, p= 0.048) and sessions to criterion (t (14) =1.95, p=0.035).
Performance across days of acquisition (Fig. 7) revealed a significant main effect of drug treatment on overall accuracy (F (1, 10) =5.2, p=0.046) and number of correction trials (F (1, 10) =6.4, p=0.03), but no drug×session interactions (accuracy: F (8.09, 80.9) =0.58, p=0.77; correction trials: F (3.91, 39.2) =0.95, p=0.44).
Analysis was also conducted in terms of stage of reversal, through early sessions (sessions 1-2) and mid-late sessions (considering sessions 3-6 and 7-18 independently gave the same results as pooling). There was no significant difference in accuracy or number of correction trials in early trials (accuracy: F (1, 13) =0.068, p=0.799; correction trials: F (1, 14) =2.11, p=0.17), but the effect of scPCP on accuracy was significant through mid-late sessions (F (1, 10) =4.93, p=0.041). Analysis of the perseveration index, the ratio of correction trials to initially incorrect responses, showed no significant difference overall (F (1, 10) =1.17, p=0.30) or in early sessions (F (1, 10) = 4.62, p=0.067) between sham and lesion. A significant effect of drug treatment on log transformed response latency was seen in early sessions (F (1, 10) =5.71, p= 0.038) with vehicle rats initially responding significantly more rapidly. This initial difference was not observed through later sessions (F (1, 10) =4.23, p=0.67), and there was no significant drug×session interaction (F (5.89, 70.74) =1.74, p=0.60) . No significant effect of drug was seen on log transformed magazine latency in early sessions (F (1, 10) =0.20, p=0.664), late sessions (F (1, 10) =2.03, p=0.184) or overall (F (1, 10) =1.79, p= 0.210).
Experiment 3: mPFC dysfunction and reversal learning
Histological results Analysis of histology confirmed lesions of the medial prefrontal cortex in all rats, centred on the prelimbic cortex, with damage to the infralimbic cortex and overlying anterior cingulate (Fig. 8) . Sham animals did not show damage to any of those regions, and one lesioned animal was excluded due to more unilateral lesion than common (Fig. 9) .
Behavioural results Rats were rebaselined for three sessions of the original discrimination post-surgery, which all subjects completed at criterion level (>80 %). mPFC rats were significantly faster in number of sessions required to reach the reversal learning criterion (t (12) = 2.52, p = 0.013), and also showed a near-significant reduction in the number of errors to criterion (t (12) =1.71, p=0.056).
Analysis of accuracy over the course of reversal found no significant effect of lesion during early trials (F (1, 11) =4.18, p=0.086), mid-trials (3-6; F (1, 11) =4.12, p=0.067), late trials (7-18; F (1, 11) =2.57, p=0.14) or across mid-late sessions (F (1, 11) =3.2, p=0.10). There was no significant difference in number of correction trials in early trials only (F (1, 11) =0.53, p= 0.48) or mid-late trials only (F (1, 11) =2.22, p=0.16).
The perseveration index showed no significant effect of lesion (F (1, 10) =0.44, p=0.52). There was no difference in reaction time (F (1, 11) =0.074, p=0.79) with reaction time decreasing as the reversal progressed (F (7.7, 84.9) = 34.1, p<0.001). There was no effect of lesion on magazine latency (F (1, 11) =0.001, p=0.98) with latency roughly remaining constant as the reversal progressed in both groups (F (1.23, 13.53) = 4.01, p=0.059).
Discussion
There was a double-dissociation between object-location paired-associates learning and object recognition: mPFC dysfunction impaired acquisition of the object-location task but not spontaneous novel object recognition, while scPCP impaired spontaneous novel object recognition but not objectlocation associative learning. Both scPCP and mPFC dysfunction resulted in a similar facilitation during the late stages of reversal learning.
Object-location learning (experiment 1)
Whereas most tests of cognitive function following scPCP are conducted immediately post-washout, observed impairments on object recognition following PAL acquisition indicate the lack of effect of scPCP on PAL was not due to a decrease in general efficacy of the manipulation across time.
Previous studies have suggested that scPCP can impair object-location learning. For example, 5 mg/kg scPCP induced a deficit in rats' ability to simultaneously associate object-place-context (O-P-C) to identify novel objects (Le Cozannet et al. 2010) . That task, however, relies on one-trial spontaneous object recognition (known to be impaired following scPCP, see below). This lower-order failure could underlie the observed impairment in other studies of object-location learning.
While a significant main effect of lesion was observed, the effect of the lesion manifests as a selective impairment in the later stages of acquisition. To investigate further how this task is solved, and thus perhaps illuminate the impairment seen following mPFC dysfunction, we carried out an objectlocation challenge ('sPAL'; Talpos et al. 2009 ). With only six unique trial types, it is conceivable that animals were Paxinos and Watson (2007) . Composite photomicrograph presents a contrast between sham (left) and lesion (right) for demonstration purposes responding to trial types as a whole picture or scene (a 'gestalt') rather than individual objects situated in individual locations, perhaps applying conditional rules by trial type.
Correct object-location associations should result in completion of sPAL with little difficulty, whereas a strategy based on the combination of objects presented during the trial would not work. Analysis showed no impairment in either group switching to sPAL, suggesting that both sham and lesion groups were not using a 'gestalt' trial-type strategy. The mPFC group was still impaired relative to sham, and their performance on sPAL dropped roughly the same amount (but not to chance). This pattern suggests that the residual performance of mPFC lesioned group was due to some preserved object-location learning but that this learning was not a rapid as in controls.
In addition, analysis of variability in performance across trial types was quite revealing: in sham animals, performance on the different trial types was highly variable during first sessions, then appeared to briefly converge, before performance across all trial types increased more uniformly. This pattern may reflect a transition from an 'elemental' strategy, or perhaps stimulus bias (responding preferentially to particular stimuli), to an object-location configural/associative solution.
Interestingly, the PFC-lesioned rats showed a very different pattern of performance (Fig. 4) . Like shams, rats in the PFC group appear to have approached the task with an elemental strategy or stimulus bias (indicated by the high variability across trial types during initial acquisition). The variance then decreases as rats relinquish this strategy or bias. Thereafter, however, performance differs markedly: whereas the sham animals' performance increases and the trial-type variance decreases, the mPFC rats' performance increases little and the variance remains the same. This pattern of results, and the pattern obtained in the sPAL probe analysis, suggests that in the later stages of PAL acquisition, rats master objectlocation associations, and that mPFC dysfunction impairs the ability to progress through this stage of the task. The idea that mPFC dysfunction impairs object-location binding is consistent with previous reports (Barker et al. 2007; Barker and Warburton 2011) .
Object recognition (experiment 2)
scPCP treatment produced a robust impairment on object recognition in keeping with previous studies (Arnt et al. 2010; Grayson et al. 2007 Grayson et al. , 2014 Horiguchi et al. 2011; Snigdha et al. 2010 Snigdha et al. , 2011 . This impairment is not the result of general differences in the exploration of objects, as evidenced by the roughly equal exploration times during the sample phase. The effects of scPCP treatment were shown to be surprisingly long-lasting, affecting SOR 40 days post-washout. However, the effects of scPCP was also time-limited, with no effect at even a 24-h delay after 105 days. A caveat is that this comparison is made within subject, without a between-subject control for order of testing. However, it seems unlikely that the substantial difference between effects of scPCP at 40 and 150 days was due to this factor alone.
The neurobiological changes underlying this impairment remain unclear, and myriad effects are observed following scPCP treatment (Egerton et al. 2005; Neill et al. 2010; Neill et al. 2014) . In particular, studies have shown that scPCP treatment downregulates striatal D1 and upregulates cortical 5-HT1A receptor binding in rats (Choi et al. 2009 ). Investigation of the amelioration of scPCP-induced impairments in novel object recognition implicate these mechanisms, as the Fig. 9 Effects of mPFC lesions on reversal learning; errors and sessions to criterion. Means±1 SEM. *p<0.05 D1 receptor agonist asenapine ameliorates a scPCP-induced impairment in object recognition, unless co-treated with the D1 antagonist SCH-23390 (Snigdha et al. 2011 ). Coadministration of atypical antipsychotics with PCP prevent development of novel object recognition deficits (Oyamada et al. 2015) . Further studies with D1 agonists (McLean et al. 2009 ) or atypical antipsychotics (Grayson et al. 2007 ) have also demonstrated amelioration of impairments in object recognition. Additionally, the 5-HT6 receptor antagonist Lu AE58054 has been shown to rescue scPCP induced impairment in object recognition (Arnt et al. 2010) .
A lack of effect of mPFC lesions on object recognition is in keeping the literature published on various forms of spontaneous object recognition (Barker et al. 2007; Ennaceur et al. 1997; Hannesson et al. 2004) .
A double-dissocation between object-location learning and object recognition
The effects of scPCP dissociated across tasks: while scPCP did not impair object-location paired-associates learning, it did impair spontaneous object recognition. This may appear paradoxical, as object recognition could seem to be required for paired-associates learning (for example, lesions to the perirhinal cortex impaired both object recognition and an object-in-place task (Barker and Warburton 2011) , although perirhinal cortex lesions have not been tested with the touchscreen PAL task used here). However, the repeated exposure to trial types and gradual learning in touchscreen paired-associates learning may be a fundamental difference between these tasks. Unlike object recognition, which is regarded (rightly or wrongly; Bussey et al. 2013 ) as one-trial learning, PAL was learned across sessions over many days. Perirhinal cortex dysfunction can impair discrimination learning across sessions in the touchscreen (Winters et al. 2010) , although the photographic stimuli used in that study were more complex than those used here, and it has been shown that perirhinal lesions can impair complex but not simple discriminations (Bussey et al. 2003) . Another possibility is that scPCP affected structures other than perirhinal cortex that are important for object recognition, for example mediodorsal thalamus (Aggleton and Mishkin 1983; Mumby et al. 1993) .
The effects of mPFC cortex dysfunction were also observed to dissociate across tasks, but in the opposite direction: lesions impaired PAL but not object recognition. This likely reflects the higher-order nature of the PAL task, which requires integrating information about object and location. This interpretation is consistent with the findings of Barker et al. (2007) , who report impairment following PFC dysfunction on an object-location task (but not on simpler object or location recognition tasks).
Thus, experiments 1 and 2 demonstrate a double dissociation between scPCP and PFC dysfunction on PAL and object recognition tasks. The object recognition data show that scPCP affects structures outside the PFC that are important for object recognition. More surprisingly, perhaps, the PAL experiments show that if scPCP induces mPFC dysfunction, it is not of sufficient magnitude to mimic the impairments found after excitotoxic mPFC dysfunction on this task.
Reversal learning (experiment 3)
Rodent models of schizophrenia have often demonstrated impaired acquisition, impaired reversal, and/or increased perseveration in various testing paradigms (Brigman et al. 2006 (Brigman et al. , 2008 Zhuo et al. 2007 ). In contrast, in the present experiment, scPCP facilitated performance during the later sessions of reversal. scPCP-treated animals did not display any differences from vehicle-treated animals when performing below 50 % correct, indicating that increased perseveration is not resulting from the scPCP treatment.
While certain other models of schizophrenia have not displayed increased perseveration (e.g. Brigman et al. 2008) , they have shown impaired learning of the new S+ vs. S− contingency. However, scPCP treatment did not impair acquisition or reversal of a visual discrimination in mice (Brigman et al. 2009 ) or rats (Fellini et al. 2014) . Unlike these previous studies, in the present study performance during late reversal was actually facilitated, with PCP-treated rats reaching asymptote at a higher level of performance than their vehicletreated controls. However, selective late-stage facilitation has been previously observed in touchscreen reversal learning conducted under similar conditions. In mice, both mild stress and ventromedial prefrontal cortex lesions selectively facilitated late reversal (Graybeal et al. 2011) . The authors note that in other studies, chronic stress can promote habit-like responding in rats (coupled with atrophy of mPFC and the 'associative' striatum and hypertrophy of the 'sensorimotor' striatum, as in (Dias-Ferreira et al. 2009 ). Indeed, lesions of the dorsolateral striatum impaired touchscreen reversal in mice; see Graybeal et al. (2011) supplementary materials. The effects of scPCP might be understood using a similar explanation: dysfunction of the ventromedial prefrontal cortex (vmPFC) removes inhibition on the dorsolateral striatum, and thus facilitates striatal-mediated habit formation late in the reversal. However, combined with the results from experiment 1, such an explanation suggests that mPFC dysfunction induced by scPCP was sufficient to facilitate transition to habit but insufficient to produce an impairment in PAL. Alternatively, other mechanisms such as direct disinhibition of the striatum might underlie the scPCP-induced improvement.
Like scPCP treatment, and consistent with previous studies, mPFC dysfunction did not impair reversal learning (Boulougouris et al. 2007; Chudasama et al. 2001 ) and indeed, according to sessions and errors to criterion, significantly facilitated it. Visual inspection indicates that like scPCP, facilitation appears in the late but not the early, perseverative stage of reversal. A difference between the pattern of data in the two experiments is that the (sham-lesioned) control rats eventually reached the same performance level as the mPFClesioned rats, whereas the vehicle-treated rats never quite reached the same level as the scPCP-treated rats. There was also more variability in the mPFC lesion group than there was in the scPCP-treated group. Taking these considerations into account, and the uncommon pattern of late reversal facilitation in both experiments, we conclude that the effects of scPCP and mPFC dysfunction were similar. However, neither manipulation looks like what one would expect from a 'complete' model of schizophrenia, in which reversal learning is, if anything, impaired (Leeson et al. 2009; Murray et al. 2008; Waltz and Gold 2007) .
That mPFC dysfunction did not produce impairment in touchscreen reversal learning is consistent with previous literature (Bussey et al. 1997 ; although impairments were obtained with perceptually difficult stimuli). Previously, dissociations have been observed between regions of the prefrontal cortex: orbitofrontal cortex lesions impair reversal learning, while mPFC lesions impair attentional set shifting (Bissonette et al. 2013; McAlonan and Brown 2003; Dias et al. 1996) . Indeed, vmPFC lesions in mice led to a late facilitation similar to that observed here (Graybeal et al. 2011) . Coupled with the finding that BDNF infusions into the vmPFC prevent reversal facilitation by stress, and the effects of striatal lesions, Graybeal et al. proposed a mechanism whereby vmPFC dysfunction disinhibits habit formation by striatal systems (see discussion of experiment 3 above, Graybeal et al. 2011) . A similar mechanism may underlie the late facilitation seen in the scPCP-treated rats, and/or the trend toward facilitation shown by the mPFC-lesioned rats, in the present study.
Evaluating scPCP as a model for schizophrenia
The use of phencyclidine to model schizophrenia has received some criticism (Brigman et al. 2010; Domino and Luby 2012) . As schizophrenia is characterized by hypofunction of the prefrontal cortex (Andreasen et al. 1992; Carter et al. 1998; Glahn et al. 2005; Hill et al. 2004) , in the present experiments, we asked the specific question of whether the cognitive impairments following scPCP resemble those following mPFC dysfunctions. These findings may be useful to consider when choosing a rodent model for studies into schizophrenia, particularly if importance is placed on the model faithfully reproducing the effects of mPFC dysfunction. Considering each of the three tasks in turn:
Object-location learning Although scPCP had no effect on PAL, schizophrenic patients are impaired on the CANTAB version of PAL (Bartok et al. 2005) . Great caution must be taken, however, in using this contrast alone to conclude that scPCP is a poor model, as we do not yet have a complete idea to what extent rodent PAL and CANTAB-PAL depend on the same psychological and neural mechanisms. Although some evidence suggests they do, for example performance of rodent PAL and CANTAB-PAL both involve the hippocampus (de Rover et al. 2011; Owen et al. 1995; Talpos et al. 2008; Kim et al. 2015) and mutations in the schizophrenia-related gene dlg2 can lead to impairments in both rodent PAL and CANTAB-PAL (Nithianantharajah and Grant 2013) . However, scPCP did not replicate the effects of mPFC dysfunction on this task.
Object recognition scPCP clearly and reproducibly impaired OR. Thus, scPCP combined with SOR may be a good model for testing schizophrenia-relevant cognitive enhancers. However, the lack of effect of mPFC dysfunction on OR suggests that the effect of scPCP was not due to dysfunction of the mPFC. Furthermore, a caveat regarding the use of SOR is that it has been argued that schizophrenics are not impaired on familiarity-based item recognition as measured by SOR but are impaired only when recollective processes are required (Huron et al. 1995; van Erp et al. 2008) .
Reversal learning Schizophrenic patients are impaired on touchscreen reversal learning, yet scPCP in the present experiment not only did not impair reversal learning but also facilitated switching to the new contingency. Other researchers have similarly observed a lack of impairment following scPCP on touchscreen reversal learning (Brigman et al. 2009; Fellini et al. 2014 ) and in attentional set-shifting paradigms (Egerton et al. 2005; McLean et al. 2012; Rodefer et al. 2005 Rodefer et al. , 2008 . Thus, to the extent that researchers wish a model replicate the impairments in reversal learning seen in schizophrenia, scPCP may not be the best choice. It should be noted, however, that reversal impairments following scPCP have been observed using other methodology, for example in operant chambers (Abdul-Monim et al. 2007; Idris et al. 2010; McLean et al. 2009 McLean et al. , 2010 and in some studies using the bowl-digging version of the task (Dawson et al. 2010; however, cf. Egerton et al. 2005 however, cf. Egerton et al. , 2008 McLean et al. 2008 McLean et al. , 2012 Pedersen et al. 2009; Rodefer et al. 2005 Rodefer et al. , 2008 To conclude, there was a double-dissociation between scPCP and mPFC dysfunctions on object-location paired-associates learning and object recognition, yet similar effects on reversal learning. The pattern of impairment following scPCP raises questions around its efficacy as a model of cognitive impairment in schizophrenia, particularly if importance is placed on the model faithfully reproducing the effects of mPFC dysfunction.
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